Mirum Pharmaceuticals

Advertisement

cGxPJobs Banner

Mirum Volixibat Achieves Phase 2b Success in PSC Trial

FOSTER CITY, Calif., May 4, 2026 Mirum Pharmaceuticals, Inc. has announced that its Phase 2b VISTAS clinical study of...

By cGxPwire Editor
May 6, 2026

Read More

Mirum Pharmaceuticals Presents New Data from LIVMARLI and Volixibat Programs at AASLD 2025

FOSTER CITY, Calif., November 7, 2025 — Mirum Pharmaceuticals, Inc., a biopharmaceutical company dedicated to transforming the lives of...

By cGxPwire Editor
November 7, 2025

Read More

Advertisement

cGxPJobs

Directory